ADARx Pharmaceuticals, Inc. (ADRX)
12.67
-1.49
(-10.52%)
USD |
NASDAQ |
Nov 20, 16:00
ADARx Pharmaceuticals Price to Book Value : 2.366 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.644 |
| November 18, 2026 | 2.394 |
| November 17, 2026 | 2.581 |
| November 16, 2026 | 2.614 |
| November 13, 2026 | 2.652 |
| November 12, 2026 | 2.784 |
| November 11, 2026 | 2.484 |
| November 10, 2026 | 2.534 |
| November 09, 2026 | 2.577 |
| November 06, 2026 | 2.470 |
| November 05, 2026 | 2.482 |
| November 04, 2026 | 2.793 |
| November 03, 2026 | 3.004 |
| November 02, 2026 | 2.943 |
| October 30, 2026 | 3.174 |
| October 29, 2026 | 3.333 |
| October 28, 2026 | 3.352 |
| October 27, 2026 | 3.385 |
| October 26, 2026 | 3.326 |
| Date | Value |
|---|---|
| October 23, 2026 | 3.292 |
| October 22, 2026 | 3.301 |
| October 21, 2026 | 3.199 |
| October 20, 2026 | 3.301 |
| October 19, 2026 | 3.292 |
| October 16, 2026 | 3.296 |
| October 15, 2026 | 3.305 |
| October 14, 2026 | 3.329 |
| October 13, 2026 | 3.305 |
| October 12, 2026 | 3.356 |
| October 09, 2026 | 3.32 |
| October 08, 2026 | 3.300 |
| October 07, 2026 | 3.236 |
| October 06, 2026 | 3.469 |
| October 05, 2026 | 3.557 |
| October 02, 2026 | 3.408 |
| October 01, 2026 | 3.649 |
| September 30, 2026 | 3.723 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Korsana Biosciences, Inc. | 4.342 |
| IRulya Therapeutics, Inc. | -- |
| PepGen Inc. | 2.540 |
| Q32 Bio, Inc. | 0.8677 |
| Bridgebio Oncology Therapeutics, Inc. | 0.4964 |
Price to Book Value Related Metrics
| PS Ratio | 255.06 |
| PEG Ratio | -0.0273 |
| Price to Free Cash Flow | 5.763 |
| Price | 12.67 |
| Earnings Yield | -7.09% |
| Market Cap | 1.359B |
| PEGY Ratio | -0.0273 |